UnitedHealth sues dozens of drug companies for price-fixing
(By Ayla Ellison for Becker’s Hospital Review) Health insurance giant United HealthCare Services filed a federal lawsuit Jan. 16 against
Read More
Part D/Prescription Drugs
In oversight inquiry, key Democrat seeking 10 years’ worth of pricing, sales, research data from drug companies
(By Nicholas Florko for STAT) Rep. Elijah Cummings, the Maryland Democrat chairing the House Oversight Committee, put the pharmaceutical industry
Read MoreMedicare experiment could put more pressure on insurers to save money on prescription drugs
(By Ike Swetlitz for STAT) WASHINGTON — The federal government is giving health insurance companies that run Medicare prescription drug
Read MoreHere’s what you can do about increased drug prices
The price you pay at the pharmacy for more than 250 drugs is going up again. According to date from
Read MoreDrug maker payments to doctors are linked to higher opioid overdose deaths
(By Ed Silverman for STAT) As efforts intensify to blunt the ongoing opioid crisis, a new study finds that increased
Read MoreNew drug shortages rose 27% in 2018
(By Alia Paavola for Becker’s Hospital Review) After three years of stability, the number of new drug shortages in the
Read MoreNew rules in 2019 give consumers more time and options to change their Medicare Advantage plan
The new rules in 2019 means switching to a new Medicare Advantage plan just got easier. The rule gives consumers
Read MoreSecretive ‘Rebate Trap’ Keeps Generic Drugs For Diabetes And Other Ills Out Of Reach
(By Jay Hancock and Sydney Lupkin for Kaiser Health News) Lisa Crook was lucky. She saved $800 last year after
Read MoreTrump’s drug plan could lower total spending, but increase patient costs, study finds
(By Morgan Haefner for Becker’s Hospital Review) While a new proposal from the Trump administration may lead to reductions in
Read MorePrice-shifting Strategies Could Affect Patients’ Out-of-pocket Costs
In a post on www.reuters.com, Reuters reporter Lisa Rapaport examines proposals on the table to reduce drug spending primarily through shifting
Read More